10-Q

UNITED STATES SECURITIES & EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly Period Ended September 30, 2021

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from         to

Commission File Number: 0-17449

PROCYON CORPORATION

(Exact Name of Registrant as specified in its charter)

Colorado	59-3280822
(State of Incorporation)	(I.R.S. Employer Identification Number)

164 Douglas Road East, Oldsmar, FL 34677

(Address of Principal Executive Offices)

(727) 447-2998

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: Common stock, no par value; 8,087,388 shares outstanding as of November 16, 2021.

PART I. - FINANCIAL INFORMATION

Item		Page
ITEM 1. FINANCIAL STATEMENTS		3
Index to Financial Statements Financial Statements:
Consolidated Balance Sheets		3
Consolidated Statements of Operations		4
Consolidated Statements of Changes in Stockholders’ Equity		5
Consolidated Statements of Cash Flows		6
Notes to Consolidated Financial Statements		7
ITEM 2.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	13
ITEM 4.	CONTROLS AND PROCEDURES	16
PART II. - OTHER INFORMATION
ITEM 5. OTHER INFORMATION		17
ITEM 6. EXHIBITS		17
SIGNATURES		18

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

September 30, 2021 and June 30, 2021 (as restated)

	(unaudited)			(audited)
	September 30,			June 30,
	2021			2021
ASSETS
CURRENT ASSETS
Cash	$	1,015,495		$	1,226,522
Certificates of Deposit, plus accrued interest		280,438			280,438
Accounts Receivable, less allowance for doubtfull accounts of $9,408 and $9,408 respectively.		640,054			497,358
Inventories		712,800			591,058
Prepaid Expenses		277,949			276,251
TOTAL CURRENT ASSETS		2,926,736			2,871,627
PROPERTY AND EQUIPMENT, NET		121,534			109,275
OTHER ASSETS
Deposits		2,443			3,235
Inventories		263,770			263,280
Intangible Asset		17,000			17,000
ROU Assets - Operating Leases		838,762			882,344
Deferred Tax Asset, Net of Valuation Allowance of $6,288 and $0, respectively		96,657			120,430
		1,218,632			1,286,289
TOTAL ASSETS	$	4,266,902		$	4,267,191
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts Payable	$	254,088		$	167,588
Accrued Expenses		322,606			413,977
Lease Liability, Current		156,126			154,022
TOTAL CURRENT LIABILITIES		732,820			735,587
LONG TERM LIABILITIES
Lease Liability - Long Term		613,856			653,860
TOTAL LONG TERM LIABILITIES		613,856			653,860
TOTAL LIABILITIES		1,346,676			1,389,447
COMMITMENTS AND CONTINGENCIES		-			-
STOCKHOLDERS' EQUITY
Preferred Stock, 496,000,000 shares authorized, none issued.		-			-
Series A Cumulative Convertible Preferred Stock, no par value; 4,000,000 shares authorized; 167,100 shares issued and outstanding.		126,860			126,860
Common Stock, no par value, 80,000,000 shares authorized; 8,087,388 shares issued and outstanding.		4,444,766			4,444,766
Paid-in Capital		35,564			35,564
Accumulated Deficit		(1,686,964	)		(1,729,446	)
TOTAL STOCKHOLDERS' EQUITY		2,920,226			2,877,744
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	4,266,902		$	4,267,191

The accompanying notes are an integral part of these financial statements.

-3-

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended September 30, 2021 and 2020

	(unaudited)			(unaudited)
	Three Months			Three Months
	Ended			Ended
	Sep. 30, 2021			Sep. 30, 2020
NET SALES	$	1,189,978		$	1,246,243
COST OF SALES		328,253			334,320
GROSS PROFIT		861,725			911,923
OPERATING EXPENSES
Salaries and Benefits		439,459			412,254
Selling, General and Administrative		356,382			283,120
		795,841			695,374
INCOME FROM OPERATIONS		65,884			216,549
OTHER INCOME
Interest Income		371			283
		371			283
INCOME BEFORE INCOME TAXES		66,255			216,832
INCOME TAX (EXPENSE)		(23,773	)		2,264
NET INCOME		42,482			219,096
Dividend requirements on preferred stock		(4,177	)		(4,177	)
Basic net income available to common shares	$	38,305		$	214,919
Basic net income per common share	$	0.00		$	0.03
Weighted average number of common shares outstanding		8,087,388			8,087,388
Diluted net income per common share	$	0.00		$	0.03
Weighted average number of common shares outstanding, diluted		8,332,228			8,319,488

The accompanying notes are an integral part of these financial statements.

-4-

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

For the Three Months Ended September 30, 2021 and 2020

Three Months Ended September 30, 2020	Preferred Stock				Common Stock				Paid-In		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Capital		Deficit			Equtiy
Balance, June 30, 2020		167,100	$	126,860		8,087,388	$	4,444,766	$	15,885	$	(2,423,795	)	$	2,163,716
Net Income		-		-		-		-		-		219,096			219,096
Balance, September 30, 2020		167,100	$	126,860		8,087,388	$	4,444,766	$	15,885	$	(2,204,699	)	$	2,382,812

Three Months Ended September 30, 2021	Preferred Stock				Common Stock				Paid-In		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Capital		Deficit			Equtiy
Balance, June 30, 2021 (As restated)		167,100	$	126,860		8,087,388	$	4,444,766	$	35,564	$	(1,729,446	)	$	2,877,744
Net Income		-		-		-		-		-		42,482			42,482
Balance, September 30, 2021		167,100	$	126,860		8,087,388	$	4,444,766	$	35,564	$	(1,686,964	)	$	2,920,226

The accompanying notes are an integral part of these financial statements.

-5-

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ending September 30, 2021 and 2020

	(unaudited)			(unaudited)
	September 30,			September 30,
	2021			2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income	$	42,482		$	219,096
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		8,215			11,413
Right of Use Asset Amortization		43,582			11,764
Deferred Income Taxes		17,485			54,375
Valuation Allowance		6,288			(56,639	)
Accrued Interest on Certificates of Deposit		-			(143	)
Decrease (increase) in:
Accounts Receivable		(142,696	)		(162,625	)
Deposits		792			-
Inventory		(122,232	)		104,953
Prepaid Expenses		(1,698	)		(58,305	)
ROU Asset		-			(34,798	)
Increase (decrease) in:
Accounts Payable		86,500			(95,752	)
Accrued Expenses		(91,371	)		(34,307	)
NET CASH (USED IN) / PROVIDED BY OPERATING ACTIVITIES		(152,653	)		(40,968	)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of property & equipment		(20,474	)		(6,786	)
NET CASH (USED IN) INVESTING ACTIVITIES		(20,474	)		(6,786	)
CASH FLOW FROM FINANCING ACTIVITIES
Increase in Operating Lease Liability		(37,900	)		55,603
NET CASH PROVIDED BY /(USED IN) FINANCING ACTIVITIES		(37,900	)		55,603
NET CHANGE IN CASH		(211,027	)		7,849
CASH AT BEGINNING OF PERIOD		1,226,522			665,834
CASH AT END OF PERIOD	$	1,015,495		$	673,683
SUPPLEMENTAL DISCLOSURES
Interest Paid	$	-		$	-
Taxes Paid	$	-		$	-

NONCASH DISCLOSURE                

During the quarter ended September 30, 2020, we increased a Right of Use Asset and corresponding lease liability in the amount of $34,798

The accompanying notes are an integral part of these financial statements.

-6-

Notes to Financial Statements

NOTE A - SUMMARY OF ACCOUNTING POLICIES

The interim consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted as allowed by such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements dated June 30, 2021, and as contained in the amendment of the Company's annual report on Form 10-K/A, as filed with the Securities and Exchange Commission on November 12, 2021, and which contain certain restatements to the June 30, 2021 financial statements. The results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Management of the Company has prepared the accompanying unaudited condensed consolidated financial statements prepared in conformity with generally accepted accounting principles, which require the use of management estimates, contain all adjustments (including normal recurring adjustments) necessary to present fairly the operations and cash flows for the period presented and to make the financial statements not misleading.

STOCK-BASED COMPENSATION

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.

On September 30, 2021, there were 65,000 outstanding options to purchase shares of our common stock granted under our prior 2009 Stock Option Plan. There were 50,000 outstanding options to purchase shares of our common stock granted under our 2020 Stock Option Plan.

The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were no options granted during the quarter ended September 30, 2021.

The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.

EARNINGS PER SHARE

Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.

- 7-

 

For the three months ended September 30, 2021, and 2020, the potential dilutive effects of the preferred stock and stock options were included in the weighted-average shares outstanding.

NOTE B - INVENTORIES

Inventories consisted of the following:

	September 30,		June 30,
	2021		2021
Finished Goods	$	764,589	$	683,771
Raw Materials		211,981		170,567
	$	976,570	$	854,338

At September 30, 2021 and June 30, 2021, respectively, $263,770 and $263,280 of our inventory was considered non-current as it will not be used within a one year period.

NOTE C - STOCKHOLDERS' EQUITY

During January 1995, the Company's Board of Directors authorized the issuance of up to 4,000,000 shares of Series A Cumulative Convertible Preferred Stock ("Series A Preferred Stock"). The preferred stockholders are entitled to receive, as and if declared by the board of directors, quarterly dividends at an annual rate of $.10 per share of Series A Preferred Stock per annum. Dividends will accrue without interest and will be cumulative from the date of issuance of the Series A Preferred Stock and will be payable quarterly in arrears in cash or publicly traded common stock when and if declared by the Board of Directors. As of September 30, 2021, no dividends have been declared. Dividends in arrears on the outstanding preferred shares total $408,694 as of September 30, 2021.

Holders of the Preferred Stock have the right to convert their shares of Preferred Stock into an equal number of shares of Common Stock of the Company. In addition, Preferred Stock holders have the right to vote the number of shares into which their shares are convertible into Common Stock. Such preferred shares will automatically convert into one share of Common Stock at the close of a public offering of Common Stock by the Company provided the Company receives gross proceeds of at least $1,000,000, and the initial offering price of the Common Stock sold in such offering is equal to or in excess of $1 per share. The Company is obligated to reserve an adequate number of shares of its common stock to satisfy the conversion of all the outstanding Series A Preferred Stock. There were no shares converted during the reporting period. So long as any share of Series A Preferred Stock is outstanding, the Company is prohibited from declaring dividends or other distributions related to its Common Stock or purchasing, redeeming or otherwise acquiring any of the Common Stock.

NOTE D - INCOME TAXES AND AVAILABLE CARRYFORWARD

As of September 30, 2021, the Company had consolidated income tax net operating loss ("NOL") carryforwards for federal income tax purposes of approximately $449,000. The NOL will expire in various years ending through the year 2035. The utilization of certain loss carryforwards are limited under Section 382 of the Internal Revenue Code.

- 8-

 

The components of the provision for income tax (expense) attributable to continuing operations are as follows:

	Three Months 9/30/2021			Three Months 9/30/2020
Current
Federal	$	0		$	0
State		0			0
	$	0		$	0
Deferred
Federal	$	(19,698	)	$	1,876
State		(4,075	)		388
	$	(23,773	)	$	2,264
Total Income Tax Benefit / (Expense)	$	(23,773	)	$	2,264

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

	Non-Current
Deferred tax assets
NOL and contribution carryforwards	$	113,759
Share based payments		4,988
Lease liabilities - operating leases		195,152
Accrued compensated absences		5,019
Accrued bonus		24,862
Allowance for doubtful accounts		2,384
Total deferred tax assets		346,164
Deferred tax (liabilities)
Right-of-use-assets - operating leases		(212,584	)
Excess of tax over book depreciation		(30,635	)
Total deferred tax (liabilities)		(243,219	)
Total deferred tax asset		102,945
Valuation Allowance		(6,288	)
Net Deferred Tax Asset	$	96,657
The change in the valuation allowance is as follows:
June 30, 2021	$	-
September 30, 2021	$	6,288
	$	6,288

- 9-

 

Income taxes for the three months ended September 30, 2021 and 2020 differ from the amounts computed by applying the effective income tax rate of 25.35%, to income before income taxes as a result of the following:

	Three Months			Three Months
	September 30, 2021			September 30, 2020
Expected (provision) at US statutory rate	$	(14,024	)	$	(45,535	)
State income tax net of federal (provision)		(2,902	)		(9,421	)
Nondeductible Expense		(559	)		(952	)
Change in estimates of loss carryforward		-			1,534
Change in valuation allowance		(6,288	)	$	56,638
Income Tax (Expense)	$	(23,773	)	$	2,264

The earliest tax year still subject to examination by a major taxing jurisdiction is fiscal year end June 30, 2018.

The Company performed a review of its uncertain tax positions in accordance with Accounting Standards Codification ASC 740-10 "Uncertainty in Income Taxes". In this regard, an uncertain tax position represents the Company's expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. As a result of this review, the Company concluded that at this time there are no uncertain tax positions, and there has been no cumulative effect on retained earnings.

NOTE E - LINE OF CREDIT

A new line of credit was procured in June 2021, with a new bank. The limit for this line of credit is $250,000 as well. Terms of the Line of credit include and an interest rate that fluctuates at prime plus a half of point, interest only. The line of credit matures on June 30, 2022.

Interest expense for the years ended June 30, 2021 and the period ending September 30, 2021, was $0 and $0, respectively.

- 10-

 

The line of credit is guaranteed by Justice W. Anderson, President and Chief Executive Officer.

NOTE F - PAYCHECK PROTECTION PROGRAM LOAN

The Company applied for a loan with the Small Business Administration (the "SBA") Paycheck Protection Program ("PPP") of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the "CARES Act") in the amount of $201,000 (the "Loan"). The Loan was funded on April 13, 2020. The Company used the proceeds of the Loan for covered payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.

The Loan, which is evidenced by a promissory note (the "Note"), has a two-year term, matures on April 13, 2022, and bear interests at a rate of 1.00% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), will commence seven months from the date the Note was signed and funded. The Company did not provide any collateral or guarantees for the Loan, nor did they pay any facility charge to obtain the Loan. The Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the Loan at any time without incurring any prepayment charges.

The Loan may be forgiven partially or fully if the Loan proceeds are used for covered payroll costs, rent and utilities, provided that such amounts are incurred during the eight-week period that commenced on April 13, 2020. Any forgiveness of the Loan will be subject to approval by the SBA and will require the Companies to apply for such treatment.

The loan was forgiven by the SBA in May of 2021.

NOTE G - RECENT ACCOUNTING PRONOUNCEMENTS

In June 2016, the F ASB issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Loss (Topic 326) {44ASU 2016-13"), which updates the guidance on recognition and measurement of credit losses for financial assets. The new requirements, known as the current expected credit loss model ("CECL ") will require entities to adopt an impairment model based on expected losses rather than incurred losses. ASU 2016-13 must be adopted on a modified-retrospective approach. This update was effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. In October 2019, the F ASB approved an extension for all non-SEC filers, including small reporting companies, to extend the effective date to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Therefore, the effective date for this update will be July 1, 2023. The Company is currently evaluating the potential impact of the adoption of the new standard on its consolidated statements of financial condition and results of operations.

NOTE H - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES

Operating leases

In June 2015, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease contains a renewal option to extend the term for successive one year periods. Initial rent amount was $1,079 per month, with increases each year no more than 3%. In applying ASC 842, the Company used a lease term of 63 months and an incremental borrowing rate of 5.5% which was the borrowing rate on the Company’s line of credit with a financial institution with all accounts and general intangibles. This lease expired in September 2020. As such, the right-of-use asset has been fully amortized and its related lease liability extinguished at September 30, 2020.

- 11-

 

In February 2018, the Company entered in a lease agreement to lease warehouse space with a lease term of 39 months. The Company paid no rent for the first three months of the lease, pays $2,936 per month for the next 12 months, $3,024 per month for the next 8 months, $3,019 per month for the next 4 months, and $3,109 for the last 12 months. In applying ASC 842, the Company uses a lease term of 39 months and an incremental borrowing rate of 5.5% which was the borrowing rate on the Company’s line of credit with a financial institution.

In August 2020, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease renews on a month-to-month basis and contains an option to purchase the equipment at fair market value or return the equipment. Historically, the Company has not exercised the option to purchase at the end of the initial lease term for similar leases and simply returned the equipment at the end of the initial lease term. Initial rent amount was $574 per month. In applying ASC 842, the Company uses a lease term of 63 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

In January 2021, the Company entered in a lease agreement to lease warehouse space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $4,792.50 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

In January 2021, the Company entered in a lease agreement to lease office space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $9,372 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. The Company also incurred initial direct cost of $114,083 related to existing improvements in the leased space. This initial direct cost has been included in determining the initial ROU asset and liability amounts. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

The following is information related to the Company’s right-of-use assets and liabilities for its operating leases:

ROU assets - operating leases obtained in exchange for lease liabilities - operating leases	$	973,081
Amortization of ROU assets since lease inception	$	(134,319	)
ROU assets - operating leases at September 30, 2021	$	838,762
Lease liabilities - operating leases on adoption date and increase in lease liabilities	$	973,081
Payments on lease liabilities		(203,099	)
Lease liabilities - operating leases on September 30, 2021		769,982
Lease liabilities - operating leases due in the 12 months ending September 30, 2022		156,126
Lease liabilities - operating leases due after September 30, 2022	$	613,856

- 12-

 

Variable lease expense was $50,020 and $12,282 for the three months ended September 30, 2021 and 2020, respectively.

Weighted average remaining lease term was 4.49 years and weighted average discount rate was 3.29% at September 30, 2021.

NOTE I - CONTINGENCY

At the time of release of these financial statements, the United States is experiencing a National Emergency related to persistent health issues. Management is unable to quantify the potential duration and economic impact of mandated closures by our National, State or Local governments.

NOTE J - SUBSEQUENT EVENTS

We have evaluated subsequent events through November 17, 2021, which is the date the financial statements were available to be issued.

ITEM 2.         MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

General

You should read the following discussion and analysis in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report.

This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market and the general economy, competitive factors, changes in product mix, production delays, product recalls, manufacturing capabilities, the impact of the COVID-19 pandemic on the Company’s sales, operations and supply chain and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and financial position could differ materially from those expressed in, or implied by, such forward-looking statements.

Recent Developments

In fiscal 2021 to date, management has expanded on the services and options the Company provides for its customers. A new website for the Extremit-Ease product was created and is operational (www.extremitease.com). Management is also working on new Business to Customer (B to C) channels to provide Retail customers better opportunity to purchase our products. The Company also expanded its facilities in January, moving into approximately 18,000 square feet of office and warehouse space. This move brought the Company back under a single roof. This has already proven to be very beneficial to our operations. In fiscal 2020, AMERX’s Extremit-Ease Compression Garment line expanded with the introduction of a Tan version of the garment and matching liner. The Amerx Wound Care line was boosted by the introduction of Retention Tape to its’ line up. The Company also expanded the Helix 3 Collagen line with new sizes, made available for certain customers.

-13-

Impact of COVID-19 on Our Business

The financial effects of the COVID-19 pandemic started showing their impact on our Company in March of 2020. Due to the timing of these events, the full effect of COVID-19 on our business cannot yet be fully quantified. We have felt the effects of the COVID-19 pandemic in our operations, as management continues to dedicate time and effort researching, discussing and implementing policies and procedures necessary to navigate through the ever changing landscape the COVID-19 pandemic has and continues to provide. As an essential business, management was tasked with remaining open, while keeping our employees safe, and providing our customers, who were still able to actively provide healthcare services, with the products they need.

Updating the effects of COVID-19 on our business, currently the effects of the pandemic on our business were most severely seen in April 2020; however, this could change with news of expected spikes and potential shut down in the future. This was a direct result of the inability for customers to have elective surgery. Once elective surgeries were permitted again we have seen a steady increase in volume. We continue to monitor operations, and are still implementing procedures to keep all our employees as safe as possible. Management does not believe it will truly be able to assess the affects of COVID-19 until the pandemic is deemed to be under control, with no foreseen future impact.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The Company's condensed consolidated financial statements have been prepared in accordance with standards of the Public Company Accounting Oversight Board (United States), which require the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. A summary of those significant accounting policies can be found in the Notes to the Consolidated Financial Statements included in the Company's annual report on form 10-K, for the year ended June 30, 2021, which was filed with the Securities and Exchange Commission on October 8, 2021, and as contained in the amendment of the Company's annual report on Form 10-K/A, as filed with the Securities and Exchange Commission on November 12, 2021, and which contain certain restatements to the June 30, 2021 financial statements. The estimates used by management are based upon the Company's historical experiences combined with management's understanding of current facts and circumstances. Certain of the Company's accounting policies are considered critical as they are both important to the portrayal of the Company's financial condition and the results of its operations and require significant or complex judgments on the part of management. We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements.

Accounts Receivable Allowance

Accounts receivable allowance reflects a reserve that reduces our customer accounts and receivable to the net amount estimated to be collectible. The valuation of accounts receivable is based upon the credit-worthiness of customers and third-party payers as well as historical collection experience. Allowances for doubtful accounts are recorded as a selling, general and administrative expense for estimated amounts expected to be uncollectible from third-party payers and customers. The Company bases its estimates on its historical collection experience, current trends, credit policy and on the analysis of accounts by aging category. At September 30, 2021, and June 30, 2021, our allowance for doubtful accounts totaled $9,408 and $9,408, respectively.

-14-

Advertising and Marketing

The Company uses several forms of advertising, including sponsorships to agencies who represent the professionals in their respective fields. The Company expenses these sponsorships over the term of the advertising arrangements on a straight line basis. Other forms of advertising used by the Company include professional journal advertisements, distributor catalogs, website and mailing campaigns. These forms of advertising are expensed when incurred.

Deferred Income Taxes

Deferred income taxes are recognized for the expected tax consequences in future years for differences between the tax bases of assets and liabilities and their financial reporting amounts, based upon enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. The Company accounts for income taxes under Topic 740 - Income Tax in the Accounting Standards Codification. A valuation allowance is used to reduce deferred tax assets to the net amount expected to be recovered in future periods. The estimates for deferred tax assets and the corresponding valuation allowance require us to exercise complex judgments. We periodically review and adjust those estimates based upon the most current information available. The Company had a valuation allowance of $6,288 as of September 30, 2021 and $0 as of June 30, 2021, respectively. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.

Revenue Recognition

The Company recognizes revenue in accordance with the Financial Accounting Standards Board's (FASB) release of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606) which requires that five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation.

Stock Based Compensation

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. All share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure.

FINANCIAL CONDITION

As of September 30, 2021 the Company's principal sources of liquid assets included cash of $1,015,495, inventories of $712,800, and net accounts receivable of $640,054. The Company also has $280,438 in Certificate of Deposits. The Company had net working capital of $2,193,916, and long-term lease of $613,856, at September 30, 2021.

During the three months ended September 30, 2021 cash decreased from $1,226,522 as of June 30, 2021, to $1,015,495. Operating activities used cash of $152,653 during the period. Investing and Financing activities used cash of $20,474 and $37,900, respectively during the period.

-15-

The Company reflected a net non-current deferred tax asset of $96,657, at September 30, 2021. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.

RESULTS OF OPERATIONS

Comparison of the three months ended September 30, 2021 and 2020.

Net sales during the quarter ended September 30, 2021, were $1,189,978 as compared to the previous year's quarter net sales of $1,246,243, a decrease of $56,265, or approximately 5%. We believe decreased sales were driven by fluctuations in customer buying patterns.

Gross profit during the quarter ended September 30, 2021, was $861,725 as compared to $911,923 during the quarter ended September 30, 2020, a decrease of $50,198 or 6%. As a percentage of net sales, gross profit was approximately 72% in the quarter ended September 30, 2021, and approximately 73% in the corresponding quarter in 2020.

Operating expenses during the quarter ended September 30, 2021 were $795,841, consisting of $439,459 in salaries and benefits and $356,382 in selling, general and administrative expenses. This compares to operating expenses during the quarter ended September 30, 2020 of $695,374, consisting of $412,254 in salaries and benefits; and $283,120 in selling, general and administrative expenses. Expenses for the quarter ended September 30, 2021, increased by $100,467 or approximately 14% compared to the corresponding quarter in 2020. Salaries and Benefits increased as a result of hiring additional sales support staff and warehouse support, as well as increased salaries driven by the current economies of the available workforce. Operating expenses increased primarily due to increases in marketing expenses and expenses asscociated with tradeshows, as some shows have begun to open back up, and rent expense from our new offices.

Operating profit decreased by $150,665 to an operating profit of $65,884 for the quarter ended September 30, 2021, as compared to an operating profit of $216,549 in the comparable quarter of the prior year. The decrease in net income for the three month period, of the comparable quarter of the prior year before income taxes was primarily attributable to the increase in marketing expenses and rent associated with our new offices.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Management of the Company, with the participation of the Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934 as of the end of the period covered by this report. Based on that evaluation, management, including the Chief Executive and Chief Financial Officer, has concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective in ensuring that all material information relating to the Company required to be disclosed in this report has been made known to management in a timely manner and ensuring that this information is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and regulations, because of the identification of a material weakness in our internal controls over financial reporting, identified below, which we view as an integral part of our disclosure controls and procedures.

-16-

(b) Changes in Internal Controls Over Financial Reporting

As previously reported, our annual assessment of the internal controls over financial reporting as of June 30, 2021 revealed a deficiency that we consider to be a material weakness: inadequate segregation of duties consistent with control objectives.

During fiscal 2022, the Company will continue to address changes needed to improve segregation of duties consistent with control objectives. We have added staff to grow sales. We expect that increased sales will enable us to add support staff, specifically in the accounting and shipping departments. A secondary effect of adding more staff will address needed improvements in segregation of duties consistent with control objectives.

PART II. OTHER INFORMATION ITEM 5. OTHER INFORMATION ITEM 6. EXHIBITS

ITEM 5. OTHER INFORMATION

ITEM 6. EXHIBITS

(A) EXHIBITS

//	10.1		Restated and Amended Executive Employment Agreement effective July1, 2021 between Justice W. Anderson, Procyon Corporation and AMERX Health Care Corporation.
//	10.2		Restated and Amended Executive Employment Agreement effective July1, 2021 between James B. Anderson, Procyon Corporation and AMERX Health Care Corporation.
//	10.3		Restated and Amended Executive Employment Agreement effective July1, 2021 between George O. Borak, Procyon Corporation and AMERX Health Care Corporation.
++	10.5		Business Line of Credit - Loan Agreement dated June 10, 2021
++	10.6		Business Line of Credit - Promissory Note dated June 10, 2021
**	10.7		Lease, effective January 15, 2021.
	31.1		Certification of Justice W. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)
	31.2		Certification of James B. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)
	32.1		Certification Pursuant to 18 U.S.C.§1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
	101.1	*	The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in iXBRL (Inline Extensible Business Reporting Language): (I) the Condensed Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Condensed Consolidated Financial Statements
	104		Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)
	*		Furnished, not filed
	//		Incorporated by reference to the Company’s form 8-K filed on or about July 28, 2021.
	++		Incorporated by reference to the Company’s form 10-K filed on or about October 28, 2021.
	**		Incorporated by reference to the Company’s form 8-K filed on or about February 28, 2021.

-17-

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

	PROCYON CORPORATION
November 19, 2021	By:/s/ JUSTICE W. ANDERSON
Date	Justice W. Anderson, Chief Executive Officer

-18-

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Justice W. Anderson, Chief Executive Officer of Procyon Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Procyon Corporation

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 19, 2021

/s/ JUSTICE W. ANDERSON

Justice W. Anderson, Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, James B. Anderson, Chief Financial Officer of Procyon Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Procyon Corporation

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to stated material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 19, 2021

/s/ JAMES B. ANDERSON

James B. Anderson, Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. §1350,

AS ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Procyon Corporation (the "Company") on Form 10-Q for the period ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, the undersigned Chief Executive Officer and Chief Financial Officer of the Company, do each certify, to our knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: November 19, 2021

/s/ JUSTICE W. ANDERSON	/s/ JAMES B. ANDERSON
Justice W. Anderson Chief Executive Officer	James B. Anderson, Chief Financial Officer

XML

Document And Entity Information - shares	3 Months Ended
	Sep. 30, 2021	Nov. 16, 2021
Document Information [Line Items]
Entity Central Index Key	0000812306
Entity Registrant Name	PROCYON CORP
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	0-17449
Entity Incorporation, State or Country Code	CO
Entity Tax Identification Number	59-3280822
Entity Address, Address Line One	164 Douglas Road East
Entity Address, City or Town	Oldsmar
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34677
City Area Code	727
Local Phone Number	447-2998
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,087,388

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
CURRENT ASSETS
Cash	$ 1,015,495	$ 1,226,522
Certificates of Deposit, plus accrued interest	280,438	280,438
Accounts Receivable, less allowance for doubtfull accounts of $9,408 and $9,408 respectively.	640,054	497,358
Inventories	712,800	591,058
Prepaid Expenses	277,949	276,251
TOTAL CURRENT ASSETS	2,926,736	2,871,627
PROPERTY AND EQUIPMENT, NET	121,534	109,275
OTHER ASSETS
Deposits	2,443	3,235
Inventories	263,770	263,280
Intangible Asset	17,000	17,000
ROU Assets - Operating Leases	838,762	882,344
Deferred Tax Asset, Net of Valuation Allowance of $6,288 and $0, respectively	96,657	120,430
Assets, Noncurrent, Excluding Property, Plant and Equipment	1,218,632	1,286,289
TOTAL ASSETS	4,266,902	4,267,191
CURRENT LIABILITIES
Accounts Payable	254,088	167,588
Accrued Expenses	322,606	413,977
Lease Liability, Current	156,126	154,022
TOTAL CURRENT LIABILITIES	732,820	735,587
LONG TERM LIABILITIES
Lease Liability - Long Term	613,856	653,860
TOTAL LONG TERM LIABILITIES	613,856	653,860
TOTAL LIABILITIES	1,346,676	1,389,447
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common Stock, no par value, 80,000,000 shares authorized; 8,087,388 shares issued and outstanding.	4,444,766	4,444,766
Paid-in Capital	35,564	35,564
Accumulated Deficit	(1,686,964)	(1,729,446)
TOTAL STOCKHOLDERS' EQUITY	2,920,226	2,877,744
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	4,266,902	4,267,191
Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A Cumulative Convertible Preferred Stock, no par value; 4,000,000 shares authorized; 167,100 shares issued and outstanding.	$ 126,860	$ 126,860

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ / shares in Thousands	Sep. 30, 2021	Jun. 30, 2021
Accounts Receivable, allowance for doubtful accounts	$ 9,408	$ 9,408
Valuation allowance	$ 6,288	$ 0
Preferred stock, authorized (in shares)	496,000,000	496,000,000
Preferred stock, issued (in shares)	0	0
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, authorized (in shares)	80,000,000	80,000,000
Common stock, issued (in shares)	8,087,388	8,087,388
Common stock, outstanding (in shares)	8,087,388	8,087,388
Convertible Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,000,000	4,000,000
Preferred stock, issued (in shares)	167,100	167,100
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, outstanding (in shares)	167,100	167,100

XML

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
NET SALES	$ 1,189,978	$ 1,246,243
COST OF SALES	328,253	334,320
GROSS PROFIT	861,725	911,923
OPERATING EXPENSES
Salaries and Benefits	439,459	412,254
Selling, General and Administrative	356,382	283,120
Operating Costs and Expenses, Total	795,841	695,374
INCOME FROM OPERATIONS	65,884	216,549
OTHER INCOME
Interest Income	371	283
Nonoperating Income (Expense), Total	371	283
INCOME BEFORE INCOME TAXES	66,255	216,832
INCOME TAX (EXPENSE)	(23,773)	2,264
NET INCOME	42,482	219,096
Dividend requirements on preferred stock	(4,177)	(4,177)
Basic net income available to common shares	$ 38,305	$ 214,919
Basic net income per common share (in dollars per share)	$ 0.00	$ 0.03
Weighted average number of common shares outstanding (in shares)	8,087,388	8,087,388
Diluted net income per common share (in dollars per share)	$ 0.00	$ 0.03
Weighted average number of common shares outstanding, diluted (in shares)	8,332,228	8,319,488

XML

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member] Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings, Appropriated [Member]	Total
Balance (in shares) at Jun. 30, 2020	167,100	8,087,388
Balance at Jun. 30, 2020	$ 126,860	$ 4,444,766	$ 15,885	$ (2,423,795)	$ 2,163,716
Net Income (Loss)	$ 0	$ 0	0	219,096	219,096
Balance (in shares) at Sep. 30, 2020	167,100	8,087,388
Balance at Sep. 30, 2020	$ 126,860	$ 4,444,766	15,885	(2,204,699)	2,382,812
Balance (in shares) at Jun. 30, 2021	167,100	8,087,388
Balance at Jun. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,729,446)	2,877,744
Net Income (Loss)	$ 0	$ 0	0	42,482	42,482
Balance (in shares) at Sep. 30, 2021	167,100	8,087,388
Balance at Sep. 30, 2021	$ 126,860	$ 4,444,766	$ 35,564	$ (1,686,964)	$ 2,920,226

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$ 42,482	$ 219,096
Depreciation	8,215	11,413
Right of Use Asset Amortization	43,582	11,764
Deferred Income Taxes	17,485	54,375
Valuation Allowance	6,288	(56,639)
Accrued Interest on Certificates of Deposit	0	(143)
Decrease (increase) in:
Accounts Receivable	(142,696)	(162,625)
Deposits	792	0
Inventory	(122,232)	104,953
Prepaid Expenses	(1,698)	(58,305)
ROU Asset	0	(34,798)
Increase (decrease) in:
Accounts Payable	86,500	(95,752)
Accrued Expenses	(91,371)	(34,307)
NET CASH (USED IN) / PROVIDED BY OPERATING ACTIVITIES	(152,653)	(40,968)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of property & equipment	(20,474)	(6,786)
NET CASH (USED IN) INVESTING ACTIVITIES	(20,474)	(6,786)
CASH FLOW FROM FINANCING ACTIVITIES
Increase in Operating Lease Liability	(37,900)	55,603
NET CASH PROVIDED BY /(USED IN) FINANCING ACTIVITIES	(37,900)	55,603
NET CHANGE IN CASH	(211,027)	7,849
CASH AT BEGINNING OF PERIOD	1,226,522	665,834
CASH AT END OF PERIOD	1,015,495	673,683
SUPPLEMENTAL DISCLOSURES
Interest Paid	0	0
Taxes Paid	$ 0	$ 0

XML

Consolidated Statements of Cash Flows (Unaudited) (Parentheticals)	3 Months Ended
	Sep. 30, 2020 USD ($)
Increase (Decrease) in Operating Lease Right-of-use Asset	$ 34,798
Increase (Decrease) in Operating Lease Liability	$ 34,798

XML

Note A - Summary of Accounting Policies

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Significant Accounting Policies [Text Block]

NOTE A - SUMMARY OF ACCOUNTING POLICIES

The interim consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted as allowed by such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements dated June 30, 2021, and as contained in the amendment of the Company's annual report on Form 10-K/A, as filed with the Securities and Exchange Commission on November 12, 2021, and which contain certain restatements to the June 30, 2021 financial statements. The results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Management of the Company has prepared the accompanying unaudited condensed consolidated financial statements prepared in conformity with generally accepted accounting principles, which require the use of management estimates, contain all adjustments (including normal recurring adjustments) necessary to present fairly the operations and cash flows for the period presented and to make the financial statements not misleading.

STOCK-BASED COMPENSATION

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.

On September 30, 2021, there were 65,000 outstanding options to purchase shares of our common stock granted under our prior 2009 Stock Option Plan. There were 50,000 outstanding options to purchase shares of our common stock granted under our 2020 Stock Option Plan.

The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were no options granted during the quarter ended September 30, 2021.

The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.

EARNINGS PER SHARE

Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.

For the three months ended September 30, 2021, and 2020, the potential dilutive effects of the preferred stock and stock options were included in the weighted-average shares outstanding.

XML

Note B - Inventories

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Inventory Disclosure [Text Block]

NOTE B - INVENTORIES

Inventories consisted of the following:

	September 30,		June 30,
	2021		2021
Finished Goods	$	764,589	$	683,771
Raw Materials		211,981		170,567
	$	976,570	$	854,338

At September 30, 2021 and June 30, 2021, respectively, $263,770 and $263,280 of our inventory was considered non-current as it will not be used within a one year period.

XML

Note C - Stockholders' Equity

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

NOTE C - STOCKHOLDERS' EQUITY

During January 1995, the Company's Board of Directors authorized the issuance of up to 4,000,000 shares of Series A Cumulative Convertible Preferred Stock ("Series A Preferred Stock"). The preferred stockholders are entitled to receive, as and if declared by the board of directors, quarterly dividends at an annual rate of $.10 per share of Series A Preferred Stock per annum. Dividends will accrue without interest and will be cumulative from the date of issuance of the Series A Preferred Stock and will be payable quarterly in arrears in cash or publicly traded common stock when and if declared by the Board of Directors. As of September 30, 2021, no dividends have been declared. Dividends in arrears on the outstanding preferred shares total $408,694 as of September 30, 2021.

Holders of the Preferred Stock have the right to convert their shares of Preferred Stock into an equal number of shares of Common Stock of the Company. In addition, Preferred Stock holders have the right to vote the number of shares into which their shares are convertible into Common Stock. Such preferred shares will automatically convert into one share of Common Stock at the close of a public offering of Common Stock by the Company provided the Company receives gross proceeds of at least $1,000,000, and the initial offering price of the Common Stock sold in such offering is equal to or in excess of $1 per share. The Company is obligated to reserve an adequate number of shares of its common stock to satisfy the conversion of all the outstanding Series A Preferred Stock. There were no shares converted during the reporting period. So long as any share of Series A Preferred Stock is outstanding, the Company is prohibited from declaring dividends or other distributions related to its Common Stock or purchasing, redeeming or otherwise acquiring any of the Common Stock.

XML

Note D - Income Taxes and Available Carryforward

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Income Tax Disclosure [Text Block]

NOTE D - INCOME TAXES AND AVAILABLE CARRYFORWARD

As of September 30, 2021, the Company had consolidated income tax net operating loss ("NOL") carryforwards for federal income tax purposes of approximately $449,000. The NOL will expire in various years ending through the year 2035. The utilization of certain loss carryforwards are limited under Section 382 of the Internal Revenue Code.

The components of the provision for income tax (expense) attributable to continuing operations are as follows:

	Three Months 9/30/2021			Three Months 9/30/2020
Current
Federal	$	0		$	0
State		0			0
	$	0		$	0
Deferred
Federal	$	(19,698	)	$	1,876
State		(4,075	)		388
	$	(23,773	)	$	2,264
Total Income Tax Benefit / (Expense)	$	(23,773	)	$	2,264

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

	Non-Current
Deferred tax assets
NOL and contribution carryforwards	$	113,759
Share based payments		4,988
Lease liabilities - operating leases		195,152
Accrued compensated absences		5,019
Accrued bonus		24,862
Allowance for doubtful accounts		2,384
Total deferred tax assets		346,164
Deferred tax (liabilities)
Right-of-use-assets - operating leases		(212,584	)
Excess of tax over book depreciation		(30,635	)
Total deferred tax (liabilities)		(243,219	)
Total deferred tax asset		102,945
Valuation Allowance		(6,288	)
Net Deferred Tax Asset	$	96,657
The change in the valuation allowance is as follows:
June 30, 2021	$	-
September 30, 2021	$	6,288
	$	6,288

Income taxes for the three months ended September 30, 2021 and 2020 differ from the amounts computed by applying the effective income tax rate of 25.35%, to income before income taxes as a result of the following:

	Three Months			Three Months
	September 30, 2021			September 30, 2020
Expected (provision) at US statutory rate	$	(14,024	)	$	(45,535	)
State income tax net of federal (provision)		(2,902	)		(9,421	)
Nondeductible Expense		(559	)		(952	)
Change in estimates of loss carryforward		-			1,534
Change in valuation allowance		(6,288	)	$	56,638
Income Tax (Expense)	$	(23,773	)	$	2,264

The earliest tax year still subject to examination by a major taxing jurisdiction is fiscal year end June 30, 2018.

The Company performed a review of its uncertain tax positions in accordance with Accounting Standards Codification ASC 740-10 "Uncertainty in Income Taxes". In this regard, an uncertain tax position represents the Company's expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. As a result of this review, the Company concluded that at this time there are no uncertain tax positions, and there has been no cumulative effect on retained earnings.

XML

Note E - Line of Credit

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Debt Disclosure [Text Block]

NOTE E - LINE OF CREDIT

A new line of credit was procured in June 2021, with a new bank. The limit for this line of credit is $250,000 as well. Terms of the Line of credit include and an interest rate that fluctuates at prime plus a half of point, interest only. The line of credit matures on June 30, 2022.

Interest expense for the years ended June 30, 2021 and the period ending September 30, 2021, was $0 and $0, respectively.

The line of credit is guaranteed by Justice W. Anderson, President and Chief Executive Officer.

XML

Note F - Paycheck Protection Program Loan

3 Months Ended

Sep. 30, 2021

PPP Loan [Member]

Notes to Financial Statements

Unusual or Infrequent Items, or Both, Disclosure [Text Block]

NOTE F - PAYCHECK PROTECTION PROGRAM LOAN

The Company applied for a loan with the Small Business Administration (the "SBA") Paycheck Protection Program ("PPP") of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the "CARES Act") in the amount of $201,000 (the "Loan"). The Loan was funded on April 13, 2020. The Company used the proceeds of the Loan for covered payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.

The Loan, which is evidenced by a promissory note (the "Note"), has a two-year term, matures on April 13, 2022, and bear interests at a rate of 1.00% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), will commence seven months from the date the Note was signed and funded. The Company did not provide any collateral or guarantees for the Loan, nor did they pay any facility charge to obtain the Loan. The Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the Loan at any time without incurring any prepayment charges.

The Loan may be forgiven partially or fully if the Loan proceeds are used for covered payroll costs, rent and utilities, provided that such amounts are incurred during the eight-week period that commenced on April 13, 2020. Any forgiveness of the Loan will be subject to approval by the SBA and will require the Companies to apply for such treatment.

The loan was forgiven by the SBA in May of 2021.

XML

Note G - Recent Accounting Pronouncements

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Accounting Standards Update and Change in Accounting Principle [Text Block]

NOTE G - RECENT ACCOUNTING PRONOUNCEMENTS

In June 2016, the F ASB issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Loss (Topic 326) {44ASU 2016-13"), which updates the guidance on recognition and measurement of credit losses for financial assets. The new requirements, known as the current expected credit loss model ("CECL ") will require entities to adopt an impairment model based on expected losses rather than incurred losses. ASU 2016-13 must be adopted on a modified-retrospective approach. This update was effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. In October 2019, the F ASB approved an extension for all non-SEC filers, including small reporting companies, to extend the effective date to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Therefore, the effective date for this update will be July 1, 2023. The Company is currently evaluating the potential impact of the adoption of the new standard on its consolidated statements of financial condition and results of operations.

XML

Note H - Right-of-use Assets and Lease Liabilities

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

NOTE H - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES

Operating leases

In June 2015, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease contains a renewal option to extend the term for successive one year periods. Initial rent amount was $1,079 per month, with increases each year no more than 3%. In applying ASC 842, the Company used a lease term of 63 months and an incremental borrowing rate of 5.5% which was the borrowing rate on the Company’s line of credit with a financial institution with all accounts and general intangibles. This lease expired in September 2020. As such, the right-of-use asset has been fully amortized and its related lease liability extinguished at September 30, 2020.

In February 2018, the Company entered in a lease agreement to lease warehouse space with a lease term of 39 months. The Company paid no rent for the first three months of the lease, pays $2,936 per month for the next 12 months, $3,024 per month for the next 8 months, $3,019 per month for the next 4 months, and $3,109 for the last 12 months. In applying ASC 842, the Company uses a lease term of 39 months and an incremental borrowing rate of 5.5% which was the borrowing rate on the Company’s line of credit with a financial institution.

In August 2020, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease renews on a month-to-month basis and contains an option to purchase the equipment at fair market value or return the equipment. Historically, the Company has not exercised the option to purchase at the end of the initial lease term for similar leases and simply returned the equipment at the end of the initial lease term. Initial rent amount was $574 per month. In applying ASC 842, the Company uses a lease term of 63 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

In January 2021, the Company entered in a lease agreement to lease warehouse space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $4,792.50 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

In January 2021, the Company entered in a lease agreement to lease office space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $9,372 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. The Company also incurred initial direct cost of $114,083 related to existing improvements in the leased space. This initial direct cost has been included in determining the initial ROU asset and liability amounts. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

The following is information related to the Company’s right-of-use assets and liabilities for its operating leases:

ROU assets - operating leases obtained in exchange for lease liabilities - operating leases	$	973,081
Amortization of ROU assets since lease inception	$	(134,319	)
ROU assets - operating leases at September 30, 2021	$	838,762
Lease liabilities - operating leases on adoption date and increase in lease liabilities	$	973,081
Payments on lease liabilities		(203,099	)
Lease liabilities - operating leases on September 30, 2021		769,982
Lease liabilities - operating leases due in the 12 months ending September 30, 2022		156,126
Lease liabilities - operating leases due after September 30, 2022	$	613,856

Variable lease expense was $50,020 and $12,282 for the three months ended September 30, 2021 and 2020, respectively.

Weighted average remaining lease term was 4.49 years and weighted average discount rate was 3.29% at September 30, 2021.

XML

Note I - Contingency

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

NOTE I - CONTINGENCY

At the time of release of these financial statements, the United States is experiencing a National Emergency related to persistent health issues. Management is unable to quantify the potential duration and economic impact of mandated closures by our National, State or Local governments.

XML

Note J - Subsequent Events

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Subsequent Events [Text Block]

NOTE J - SUBSEQUENT EVENTS

We have evaluated subsequent events through November 17, 2021, which is the date the financial statements were available to be issued.

XML

Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Share-based Payment Arrangement [Policy Text Block]

STOCK-BASED COMPENSATION

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.

On September 30, 2021, there were 65,000 outstanding options to purchase shares of our common stock granted under our prior 2009 Stock Option Plan. There were 50,000 outstanding options to purchase shares of our common stock granted under our 2020 Stock Option Plan.

The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were no options granted during the quarter ended September 30, 2021.

The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.

Earnings Per Share, Policy [Policy Text Block]

EARNINGS PER SHARE

Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.

For the three months ended September 30, 2021, and 2020, the potential dilutive effects of the preferred stock and stock options were included in the weighted-average shares outstanding.

XML

Note B - Inventories (Tables)

3 Months Ended

Sep. 30, 2021

Notes Tables

Schedule of Inventory, Current and Noncorrent [Table Text Block]

	September 30,		June 30,
	2021		2021
Finished Goods	$	764,589	$	683,771
Raw Materials		211,981		170,567
	$	976,570	$	854,338

XML

Note D - Income Taxes and Available Carryforward (Tables)

3 Months Ended

Sep. 30, 2021

Notes Tables

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Three Months 9/30/2021			Three Months 9/30/2020
Current
Federal	$	0		$	0
State		0			0
	$	0		$	0
Deferred
Federal	$	(19,698	)	$	1,876
State		(4,075	)		388
	$	(23,773	)	$	2,264
Total Income Tax Benefit / (Expense)	$	(23,773	)	$	2,264

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	Non-Current
Deferred tax assets
NOL and contribution carryforwards	$	113,759
Share based payments		4,988
Lease liabilities - operating leases		195,152
Accrued compensated absences		5,019
Accrued bonus		24,862
Allowance for doubtful accounts		2,384
Total deferred tax assets		346,164
Deferred tax (liabilities)
Right-of-use-assets - operating leases		(212,584	)
Excess of tax over book depreciation		(30,635	)
Total deferred tax (liabilities)		(243,219	)
Total deferred tax asset		102,945
Valuation Allowance		(6,288	)
Net Deferred Tax Asset	$	96,657
The change in the valuation allowance is as follows:
June 30, 2021	$	-
September 30, 2021	$	6,288
	$	6,288

Comprehensive Income (Loss) [Table Text Block]

	Three Months			Three Months
	September 30, 2021			September 30, 2020
Expected (provision) at US statutory rate	$	(14,024	)	$	(45,535	)
State income tax net of federal (provision)		(2,902	)		(9,421	)
Nondeductible Expense		(559	)		(952	)
Change in estimates of loss carryforward		-			1,534
Change in valuation allowance		(6,288	)	$	56,638
Income Tax (Expense)	$	(23,773	)	$	2,264

XML

Note H - Right-of-use Assets and Lease Liabilities (Tables)

3 Months Ended

Sep. 30, 2021

Notes Tables

Lessee, Operating Lease, Right-of-Use Assets and Liabilities [Table Text Block]

ROU assets - operating leases obtained in exchange for lease liabilities - operating leases	$	973,081
Amortization of ROU assets since lease inception	$	(134,319	)
ROU assets - operating leases at September 30, 2021	$	838,762
Lease liabilities - operating leases on adoption date and increase in lease liabilities	$	973,081
Payments on lease liabilities		(203,099	)
Lease liabilities - operating leases on September 30, 2021		769,982
Lease liabilities - operating leases due in the 12 months ending September 30, 2022		156,126
Lease liabilities - operating leases due after September 30, 2022	$	613,856

XML

Note A - Summary of Accounting Policies (Details Textual)	3 Months Ended
	Sep. 30, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	0
The 2009 Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)	65,000
The 2020 Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)	50,000

XML

Note B - Inventories (Details Textual) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Inventory, Noncurrent, Total	$ 263,770	$ 263,280

XML

Note B - Inventories - Inventories (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Finished Goods	$ 764,589	$ 683,771
Raw Materials	211,981	170,567
Inventory, Gross, Total	$ 976,570	$ 854,338

XML

Note C - Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 1995	Sep. 30, 2021	Jun. 30, 2021
Preferred Stock, Shares Authorized (in shares)		496,000,000	496,000,000
Preferred Stock, Amount of Preferred Dividends in Arrears		$ 408,694
Minimum [Member]
Proceeds From Public Offering Required for Mandatory Conversion		$ 1,000,000
Share Price (in dollars per share)		$ 1
Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)	4,000,000	4,000,000	4,000,000
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in dollars per share)	$ 0.10
Dividends, Preferred Stock, Total		$ 0
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)		1
Conversion of Stock, Shares Converted (in shares)		0

XML

Note D - Income Taxes and Available Carryforward (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating Loss Carryforwards, Total	$ 449,000
Effective Income Tax Rate Reconciliation, Percent, Total	25.35%	25.35%
Unrecognized Tax Benefits, Ending Balance	$ 0

XML

Note D - Income Taxes and Available Carryforward - Provision for Income Tax Expense (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Federal	$ (0)	$ (0)
State	(0)	(0)
Current Federal, State and Local, Tax Expense (Benefit), Total	0	0
Federal	19,698	(1,876)
State	(4,075)	388
Deferred Federal, State and Local, Tax Expense (Benefit), Total	(23,773)	2,264
Total Income Tax Benefit / (Expense)	$ (23,773)	$ 2,264

XML

Note D - Income Taxes and Available Carryforward - Deferred Tax Assets and Liabilities (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
NOL and contribution carryforwards	$ 113,759
Share based payments	4,988
Lease liabilities - operating leases	195,152
Accrued compensated absences	5,019
Accrued bonus	24,862
Allowance for doubtful accounts	2,384
Total deferred tax assets	346,164
Right-of-use-assets - operating leases	(212,584)
Excess of tax over book depreciation	(30,635)
Total deferred tax (liabilities)	(243,219)
Total deferred tax asset	102,945
Valuation Allowance	(6,288)		$ 0
Net Deferred Tax Asset	96,657		120,430
Valuation allowance	6,288		$ 0
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 6,288	$ (56,639)

XML

Note D - Income Taxes and Available Carryforward - Income Taxes Reconciliation (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Expected (provision) at US statutory rate	$ (14,024)	$ (45,535)
State income tax net of federal (provision)	(2,902)	(9,421)
Nondeductible Expense	(559)	(952)
Change in estimates of loss carryforward	0	1,534
Change in valuation allowance	(6,288)	56,638
Total Income Tax Benefit / (Expense)	$ (23,773)	$ 2,264

XML

Note E - Line of Credit (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021
Line of Credit Facility, Maximum Borrowing Capacity		$ 250,000
Interest Expense, Debt, Total	$ 0	$ 0

XML

Note F - Paycheck Protection Program Loan (Details Textual)	Apr. 13, 2020 USD ($)
Paycheck Protection Program CARES Act [Member]
Notes Payable, Total	$ 201,000

XML

Note H - Right-of-use Assets and Lease Liabilities (Details Textual) - USD ($)	1 Months Ended				3 Months Ended
	Jan. 31, 2021	Aug. 31, 2020	Feb. 28, 2018	Jun. 30, 2015	Sep. 30, 2021	Sep. 30, 2020
Variable Lease, Cost					$ 50,020	$ 12,282
Operating Lease, Weighted Average Remaining Lease Term (Year)					4 years 5 months 26 days
Operating Lease, Weighted Average Discount Rate, Percent					3.29%
Operating Lease For Office Equipment [Member]
Lessee, Operating Lease, Term of Contract (Month)				63 months
Lessee, Operating Lease, Rent Per Month				$ 1,079
Lessee, Operating Lease, Maximum Yearly Increase of Rent				3.00%
Lessee, Operating Lease, Discount Rate					5.50%
Operating Lease for Warehouse [Member]
Lessee, Operating Lease, Term of Contract (Month)	64 months		39 months
Lessee, Operating Lease, Maximum Yearly Increase of Rent	5.00%
Lessee, Operating Lease, Discount Rate	3.25%		5.50%
Lessee, Operating Lease, Rent Per Month, First Three Months			$ 0
Lessee, Operating Lease, Rent Per Month, Following 12 Months			2,936
Lessee, Operating Lease, Rent Per Month, Following 8 Months			3,024
Lessee, Operating Lease, Rent Per Month, Following 4 Months			3,019
Lessee, Operating Lease, Rent Per Month, Last 12 Months			$ 3,109
Lessee, Operating Lease, Rent Per Month, First Four Months	$ 0
Lessee, Operating Lease, Rent Per Month, Beginning 5th Month	$ 4,792.50
Lessee, Operating Lease, Minimum Yearly Increase of Rent	2.00%
Operating Lease for Certain Office Equipment [Member]
Lessee, Operating Lease, Term of Contract (Month)		63 months
Lessee, Operating Lease, Rent Per Month		$ 574
Lessee, Operating Lease, Discount Rate		4.25%
Operating Lease for Office Space [Member]
Lessee, Operating Lease, Term of Contract (Month)	64 months
Lessee, Operating Lease, Maximum Yearly Increase of Rent	5.00%
Lessee, Operating Lease, Discount Rate	3.25%
Lessee, Operating Lease, Rent Per Month, First Four Months	$ 0
Lessee, Operating Lease, Rent Per Month, Beginning 5th Month	$ 9,372
Lessee, Operating Lease, Minimum Yearly Increase of Rent	2.00%
Operating Lease, Initial Direct Cost Expense, over Term	$ 114,083

XML

Note H - Right-of-use Assets and Lease Liabilities - Right-of-use Assets and Liabilities (Details) - USD ($)	76 Months Ended
	Sep. 30, 2021	Jun. 30, 2021
ROU assets - operating leases obtained in exchange for lease liabilities - operating leases	$ 973,081
Amortization of ROU assets since lease inception	(134,319)
ROU assets - operating leases	838,762	$ 882,344
Lease liabilities - operating leases on adoption date and increase in lease liabilities	973,081
Payments on lease liabilities	(203,099)
Lease liabilities - operating leases	769,982
Lease liabilities - operating leases due in the 12 months ending September 30, 2022	156,126	154,022
Lease liabilities - operating leases due after September 30, 2022	$ 613,856	$ 653,860